Table 4

Secondary endpoints at 24 months

Number of patientsBBCCBP value
 Intention to treat3.8%119.2%50.01
Individual endpoints of MACE
 All-cause death0%00%0NA
 Hospitalisation for non-fatal MI and unstable angina0%00%0NA
 Coronary revascularisation for stable CAD4%119%50.03
Bleeding complication0%00%0NA
Severe side effects due to medication0%04%10.18
  • Values are mean_SD or n (%).

  • BB, beta blocker; CAD, coronary artery disease; CCB, calcium channel blocker; CVD, cerebrovascular disease; MACE, major adverse cardiac events; MI, myocardial infarction; NA, not applicable.